CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
Salt Lake City, Utah, United States and 28 other locations
in treating patients with recurrent or progressive uterine endometrial cancer after platinum-based chemotherapy and immune checkpoi...
Phase 1, Phase 2
West Valley City, Utah, United States and 3 other locations
The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth f...
Phase 3
Murray, Utah, United States and 190 other locations
to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...
Phase 2
Salt Lake City, Utah, United States and 89 other locations
to Part A (Phase 1a and Phase 1b) will include ovarian and endometrial cancers. Enrollment to Part B (Phase 1a and Phase 1b) will i...
Phase 1
Salt Lake City, Utah, United States and 11 other locations
in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 65 other locations
The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.
Phase 1
West Valley City, Utah, United States of America and 26 other locations
This is a Phase 1, two-part, open-label, nonrandomized, dose-escalation and signal-seeking study of CGT6297, evaluating the safety, tolerability, PK,...
Phase 1
West Valley City, Utah, United States and 10 other locations
The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity...
Phase 1
Salt Lake City, Utah, United States and 18 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1
Salt Lake City, Utah, United States and 123 other locations
Clinical trials
Research sites
Resources
Legal